ExxonMobil (XOM) surged approximately +14.9% over the past 30 days, climbing from $136.54 on June 26 to $156.94 by July 24, 2026. The rally was primarily fueled by escalating geopolitical tensions between the U.S. and Iran, which drove crude oil prices sharply higher and disrupted Strait of Hormuz shipping lanes.

GLD gained approximately 10.7% over the last 30 days, rebounding from a multi-month nadir near $367 to trade above $406 per share. A sharply weaker-than-expected US employment report for July triggered a meaningful repricing of Federal Reserve rate expectations, reducing the opportunity cost of holding non-yielding gold.

Newmont Corporation (NEM) shares surged approximately 28.8% over the past 30 days, climbing from $93.10 on July 13 to $119.89 as of August 12, 2026. A powerful gold-price breakout — with COMEX gold rallying over 7% in a single week toward $4,400 per ounce — served as the primary catalyst for the mining sector's broad advance.

Eagle Capital Growth Fund, Inc. (GRF) is an actively managed closed-end fund pursuing long-term growth through a concentrated portfolio of approximately 29 U.S. equity holdings. The portfolio is heavily tilted toward Financial Services (37% of assets) and Consumer Cyclical (24%), with top holdings including Markel, Alphabet, and T. Rowe Price collectively representing a substantial portion of total assets.

Beyond Air (XAIR) shares declined approximately 23% over the past 30 days, falling from $7.49 on July 13 to $5.75 as of August 12, 2026. The stock posted a steeper loss of roughly 46-52% over the last quarter, reflecting persistent pressure from Nasdaq compliance concerns, a 1-for-20 reverse stock split, and ongoing cash burn.

SHEL has gained approximately 7.5% over the past 30 days, climbing from $83.98 on July 13 to $90.28 as of August 12, 2026, supported by an exceptional second-quarter earnings report. Shell's Q2 adjusted earnings more than doubled year-over-year to $9.84 billion, handily beating the consensus estimate of $8.92 billion and marking the company's second-highest quarterly profit on record.

UAMY plunged -21.73% on Wednesday, falling from a prior close of $6.58 to $5.15, with the selloff beginning in premarket trading and accelerating during the regular session. The primary catalyst was a deeply disappointing Q2 2026 earnings report released after Monday's close: revenue of $7.9M missed consensus estimates by roughly $13.8M as antimony average selling prices collapsed -52% year-over-year to $13.70 per pound.

Savers Value Village (SVV) shares surged approximately 21.9% over the last 30 days, rising from $9.68 to $11.80 as of the most recent close. The rally was fueled by strong Q2 2026 earnings results, raised full-year guidance, and enthusiasm around the company's new AI-driven ThriftIQ pricing platform.

ATEX dropped -10.50% during regular trading on Wednesday, falling from a previous close of $92.94 to $83.18 as of mid-morning. The selloff follows the release of Q1 FY2027 results after Tuesday's close: EPS of -$0.53 beat estimates by $0.02, but revenue of $1.96 million missed consensus, disappointing investors.

OCTV dropped -10.80% during regular trading after premarket losses steepened to as much as -15% following the company's Q2 2026 earnings release before the open. The company swung to a GAAP loss of $1.97 billion, or -$7.34 per share, versus a $75.2 million profit a year ago, driven by $2.14 billion in non-cash impairment charges on goodwill and brand write-downs.

BSP fell approximately -9.02% during regular trading on Wednesday, dropping from a prior close of $53.44 to an intraday low near $48.62, reversing a +2.90% premarket gain. Bank of America Securities downgraded the stock to Underperform from Neutral, warning that BSP's valuation implies ~$18 billion in future M&A that its balance sheet cannot support — only ~$7B in debt capacity is available through end-2027.

BETA Technologies shares surged approximately 41% over the past 30 days, propelled by an eight-day winning streak that added roughly $1.6 billion in market capitalization. The rally was ignited by a landmark announcement that the U.S. Export-Import Bank intends to expand its financing relationship with BETA to up to $1 billion, providing non-dilutive growth capital for manufacturing expansion.

SK hynix completed the largest-ever foreign ADR listing in U.S. history on July 10, raising $26.5 billion at $149 per ADR on Nasdaq. The stock opened its debut session at $170 and surged as high as $194.80 on July 14 before entering a consolidation phase, closing at $154.57 on July 24.

SUGP shares fell approximately 19% over the past 30 days, driven primarily by a Nasdaq delisting determination and a 1-for-5 reverse stock split aimed at regaining listing compliance. The broader quarterly trend has been even more severe, with shares declining roughly 88% over the last three months amid dilutive financing, warrant repricing, and deteriorating investor confidence.

Revenue and profit growth: Total revenue rose 6% to $2.66 billion, while operating profit from reportable segments climbed 10% to $665 million for the first half of 2026. Adjusted EPS beats expectations: Adjusted earnings per share (EPS) increased 13% to 274.7 cents, surpassing analyst consensus estimates of approximately $2.40 per share.

Revenue surged 112% year-over-year to $2.58 billion, surpassing the consensus estimate of $2.56 billion and marking the fifth consecutive revenue beat since the company's IPO. Adjusted loss per share of $1.03 came in narrower than the analyst consensus of a $1.20 loss, while GAAP (Generally Accepted Accounting Principles) net loss widened to $626 million from $290 million a year ago.

Revenue climbed 57.3% year-over-year to $580.9 million, powered by higher precious metal and energy prices, yet fell short of the consensus estimate of approximately $619 million. Adjusted earnings per share (EPS) came in at $1.81 , below the FactSet consensus of $1.96 and well under the higher-end analyst forecasts near $2.16.

Non-GAAP EPS of $2.91 surged 40% year-over-year, handily beating the consensus estimate of approximately $2.41. Revenue rose 6% to $63.7 billion , missing the consensus estimate of roughly $65.2 billion but reflecting solid demand across the pharmaceutical distribution business.

Revenue surpassed $1 billion for the first time , reaching $1.01 billion and beating consensus estimates of $984.57 million by a comfortable margin. Adjusted earnings per share (EPS) came in at $3.23 , exceeding the analyst consensus of $2.95 by $0.28 and more than tripling the $0.88 reported in the same quarter last year.

Revenue surpassed expectations: Sea Limited reported second-quarter GAAP revenue of $7.8 billion, up 48.1% year-over-year and comfortably above the consensus estimate of approximately $7.1 billion. Earnings per share came in below forecasts: Diluted earnings per share (EPS) landed at $0.70, missing Wall Street estimates that ranged from $0.86 to $1.00, though it grew 7.7% from $0.65 in the same quarter a year ago.